The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2023
|
_version_ | 1797111502033911808 |
---|---|
author | Weiss, GE Ragotte, RJ Quinkert, D Lias, AM Dans, MG Boulet, C Looker, O Ventura, OD Williams, BG Crabb, BS Draper, SJ Gilson, PR |
author_facet | Weiss, GE Ragotte, RJ Quinkert, D Lias, AM Dans, MG Boulet, C Looker, O Ventura, OD Williams, BG Crabb, BS Draper, SJ Gilson, PR |
author_sort | Weiss, GE |
collection | OXFORD |
description | The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells (RBCs). To trigger RBC invasion, PfRH5 engages with RBC protein basigin in a step termed the RH5-basigin binding stage. Although we know increasingly more about how antibodies specific for PfRH5 can block invasion, much less is known about how antibodies recognizing other members of the PCRCR complex can inhibit invasion. To address this, we performed live cell imaging using monoclonal antibodies (mAbs) which bind PfRH5 and PfCyRPA. We measured the degree and timing of the invasion inhibition, the stage at which it occurred, as well as subsequent events. We show that parasite invasion is blocked by individual mAbs, and the degree of inhibition is enhanced when combining a mAb specific for PfRH5 with one binding PfCyRPA. In addition to directly establishing the invasion-blocking capacity of the mAbs, we identified a secondary action of certain mAbs on extracellular parasites that had not yet invaded where the mAbs appeared to inactivate the parasites by triggering a developmental pathway normally only seen after successful invasion. These findings suggest that epitopes within the PfCyRPA-PfRH5 sub-complex that elicit these dual responses may be more effective immunogens than neighboring epitopes by both blocking parasites from invading and rapidly inactivating extracellular parasites. These two protective mechanisms, prevention of invasion and inactivation of uninvaded parasites, resulting from antibody to a single epitope indicate a possible route to the development of more effective vaccines. |
first_indexed | 2024-03-07T08:11:19Z |
format | Journal article |
id | oxford-uuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44b |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T08:11:19Z |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | dspace |
spelling | oxford-uuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44b2023-11-24T12:21:40ZThe dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoitesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44bEnglishSymplectic ElementsPublic Library of Science2023Weiss, GERagotte, RJQuinkert, DLias, AMDans, MGBoulet, CLooker, OVentura, ODWilliams, BGCrabb, BSDraper, SJGilson, PRThe Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells (RBCs). To trigger RBC invasion, PfRH5 engages with RBC protein basigin in a step termed the RH5-basigin binding stage. Although we know increasingly more about how antibodies specific for PfRH5 can block invasion, much less is known about how antibodies recognizing other members of the PCRCR complex can inhibit invasion. To address this, we performed live cell imaging using monoclonal antibodies (mAbs) which bind PfRH5 and PfCyRPA. We measured the degree and timing of the invasion inhibition, the stage at which it occurred, as well as subsequent events. We show that parasite invasion is blocked by individual mAbs, and the degree of inhibition is enhanced when combining a mAb specific for PfRH5 with one binding PfCyRPA. In addition to directly establishing the invasion-blocking capacity of the mAbs, we identified a secondary action of certain mAbs on extracellular parasites that had not yet invaded where the mAbs appeared to inactivate the parasites by triggering a developmental pathway normally only seen after successful invasion. These findings suggest that epitopes within the PfCyRPA-PfRH5 sub-complex that elicit these dual responses may be more effective immunogens than neighboring epitopes by both blocking parasites from invading and rapidly inactivating extracellular parasites. These two protective mechanisms, prevention of invasion and inactivation of uninvaded parasites, resulting from antibody to a single epitope indicate a possible route to the development of more effective vaccines. |
spellingShingle | Weiss, GE Ragotte, RJ Quinkert, D Lias, AM Dans, MG Boulet, C Looker, O Ventura, OD Williams, BG Crabb, BS Draper, SJ Gilson, PR The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title | The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title_full | The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title_fullStr | The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title_full_unstemmed | The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title_short | The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites |
title_sort | dual action of human antibodies specific to plasmodium falciparum pfrh5 and pfcyrpa blocking invasion and inactivating extracellular merozoites |
work_keys_str_mv | AT weissge thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT ragotterj thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT quinkertd thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT liasam thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT dansmg thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT bouletc thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT lookero thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT venturaod thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT williamsbg thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT crabbbs thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT drapersj thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT gilsonpr thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT weissge dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT ragotterj dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT quinkertd dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT liasam dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT dansmg dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT bouletc dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT lookero dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT venturaod dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT williamsbg dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT crabbbs dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT drapersj dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites AT gilsonpr dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites |